| Bioactivity | Biotin-H10 is a specific anterior gradient homolog 2 (AGR2) inhibitor with a KD of 6.4 nM. Biotin-H10 inhibits cancer cells viability[1]. |
| Target | KD: 6.4 nM (AGR2) |
| Name | Biotin-H10 |
| Sequence | {Biotin}-Gly-Gly-Gly-Ser-Gly-Met-Lys-Met-Gln-Val-Arg-Ile-Tyr-Leu-Val |
| Shortening | {Biotin}-GGGSGMKMQVRIYLV |
| Formula | C79H132N22O21S3 |
| Molar Mass | 1822.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Garri C, et al. Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2). Oncotarget. 2018 Jun 8;9(44):27363-27379. |